Your browser doesn't support javascript.
loading
Curcumin co-treatment ameliorates resistance to gefitinib in drug- resistant NCI-H1975 lung cancer cells.
Jin, Xin; Wang, Jue; Shen, Huifen; Ran, Ran; Xu, Kai; Zhang, Weiping; Tong, Xiangming; Feng, Li.
Affiliation
  • Jin X; Institute of Hematology, the First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou 310003, China.
  • Wang J; Department of Oncology, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
  • Shen H; Department of Oncology, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
  • Ran R; Department of Oncology, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
  • Xu K; Department of Oncology, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
  • Zhang W; Department of Oncology, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
  • Tong X; Institute of Hematology, Zhejiang Provincial People's Hospital, Hangzhou 310014, China.
  • Feng L; Traditional Chinese Medicine Department of National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
J Tradit Chin Med ; 37(3): 355-360, 2017 Jun.
Article in En | MEDLINE | ID: mdl-31682378
Key words
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Language: En Journal: J Tradit Chin Med Year: 2017 Document type: Article Affiliation country: China
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Language: En Journal: J Tradit Chin Med Year: 2017 Document type: Article Affiliation country: China